205 related articles for article (PubMed ID: 33297998)
1. Germline variation networks in the PI3K/AKT pathway corresponding to familial high-incidence lung cancer pedigrees.
Lin H; Zhang G; Zhang XC; Lian XL; Zhong WZ; Su J; Chen SL; Wu YL
BMC Cancer; 2020 Dec; 20(1):1209. PubMed ID: 33297998
[TBL] [Abstract][Full Text] [Related]
2. Whole Genome Sequencing of Familial Non-Medullary Thyroid Cancer Identifies Germline Alterations in MAPK/ERK and PI3K/AKT Signaling Pathways.
Srivastava A; Kumar A; Giangiobbe S; Bonora E; Hemminki K; Försti A; Bandapalli OR
Biomolecules; 2019 Oct; 9(10):. PubMed ID: 31614935
[TBL] [Abstract][Full Text] [Related]
3. Focused Analysis of Exome Sequencing Data for Rare Germline Mutations in Familial and Sporadic Lung Cancer.
Liu Y; Kheradmand F; Davis CF; Scheurer ME; Wheeler D; Tsavachidis S; Armstrong G; Simpson C; Mandal D; Kupert E; Anderson M; You M; Xiong D; Pikielny C; Schwartz AG; Bailey-Wilson J; Gaba C; De Andrade M; Yang P; Pinney SM; ; Amos CI; Spitz MR
J Thorac Oncol; 2016 Jan; 11(1):52-61. PubMed ID: 26762739
[TBL] [Abstract][Full Text] [Related]
4. A germline mutation in Rab43 gene identified from a cancer family predisposes to a hereditary liver-colon cancer syndrome.
Jiang Y; Sun Y; Hu J; Yu N; Liu H; Fan J; Ning X; Li Y; Liu B; Sun Y; Zhang J; Qiu X; Fu S; Zhou C; Xu H
BMC Cancer; 2019 Jun; 19(1):613. PubMed ID: 31226964
[TBL] [Abstract][Full Text] [Related]
5. Exome sequencing deciphers a germline MET mutation in familial epidermal growth factor receptor-mutant lung cancer.
Tode N; Kikuchi T; Sakakibara T; Hirano T; Inoue A; Ohkouchi S; Tamada T; Okazaki T; Koarai A; Sugiura H; Niihori T; Aoki Y; Nakayama K; Matsumoto K; Matsubara Y; Yamamoto M; Watanabe A; Nukiwa T; Ichinose M
Cancer Sci; 2017 Jun; 108(6):1263-1270. PubMed ID: 28294470
[TBL] [Abstract][Full Text] [Related]
6. Genetic variants in the PI3K/PTEN/AKT/mTOR pathway predict platinum-based chemotherapy response of advanced non-small cell lung cancers in a Chinese population.
Xu JL; Wang ZW; Hu LM; Yin ZQ; Huang MD; Hu ZB; Shen HB; Shu YQ
Asian Pac J Cancer Prev; 2012; 13(5):2157-62. PubMed ID: 22901187
[TBL] [Abstract][Full Text] [Related]
7. Functional Common and Rare
Bao R; Ng A; Sasaki M; Esai Selvan M; Katti A; Lee H; Huang L; Skol AD; Lavarino C; Salvador H; Klein RJ; Gümüş ZH; Mora J; Onel K
Cancer Prev Res (Phila); 2021 Apr; 14(4):441-454. PubMed ID: 33419763
[TBL] [Abstract][Full Text] [Related]
8. Identification of mutations in the PI3K-AKT-mTOR signalling pathway in patients with macrocephaly and developmental delay and/or autism.
Yeung KS; Tso WWY; Ip JJK; Mak CCY; Leung GKC; Tsang MHY; Ying D; Pei SLC; Lee SL; Yang W; Chung BH
Mol Autism; 2017; 8():66. PubMed ID: 29296277
[TBL] [Abstract][Full Text] [Related]
9. Novel candidate genes may be possible predisposing factors revealed by whole exome sequencing in familial esophageal squamous cell carcinoma.
Forouzanfar N; Baranova A; Milanizadeh S; Heravi-Moussavi A; Jebelli A; Abbaszadegan MR
Tumour Biol; 2017 May; 39(5):1010428317699115. PubMed ID: 28459198
[TBL] [Abstract][Full Text] [Related]
10. Whole-Exome Sequencing Identifies a Novel Germline Variant in
Miao B; Skopelitou D; Srivastava A; Giangiobbe S; Dymerska D; Paramasivam N; Kumar A; Kuświk M; Kluźniak W; Paszkowska-Szczur K; Schlesner M; Lubinski J; Hemminki K; Försti A; Bandapalli OR
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163215
[TBL] [Abstract][Full Text] [Related]
11. Activation of PI3K/AKT Pathway Is a Potential Mechanism of Treatment Resistance in Small Cell Lung Cancer.
Jin Y; Chen Y; Tang H; Hu X; Hubert SM; Li Q; Su D; Xu H; Fan Y; Yu X; Chen Q; Liu J; Hong W; Xu Y; Deng H; Zhu D; Li P; Gong Y; Xia X; Gay CM; Zhang J; Chen M
Clin Cancer Res; 2022 Feb; 28(3):526-539. PubMed ID: 34921019
[TBL] [Abstract][Full Text] [Related]
12. Genetic variations in cancer-related significantly mutated genes and lung cancer susceptibility.
Zhang Y; Zhang L; Li R; Chang DW; Ye Y; Minna JD; Roth JA; Han B; Wu X
Ann Oncol; 2017 Jul; 28(7):1625-1630. PubMed ID: 28383694
[TBL] [Abstract][Full Text] [Related]
13. Exosomal lncRNA FOXD3-AS1 upregulates ELAVL1 expression and activates PI3K/Akt pathway to enhance lung cancer cell proliferation, invasion, and 5-fluorouracil resistance.
Mao G; Mu Z; Wu DA
Acta Biochim Biophys Sin (Shanghai); 2021 Nov; 53(11):1484-1494. PubMed ID: 34605863
[TBL] [Abstract][Full Text] [Related]
14. Paired genomic analysis of squamous cell carcinoma transformed from EGFR-mutated lung adenocarcinoma.
Park S; Shim JH; Lee B; Cho I; Park WY; Kim Y; Lee SH; Choi Y; Han J; Ahn JS; Ahn MJ; Park K; Sun JM
Lung Cancer; 2019 Aug; 134():7-15. PubMed ID: 31319998
[TBL] [Abstract][Full Text] [Related]
15. Signaling networks associated with AKT activation in non-small cell lung cancer (NSCLC): new insights on the role of phosphatydil-inositol-3 kinase.
Scrima M; De Marco C; Fabiani F; Franco R; Pirozzi G; Rocco G; Ravo M; Weisz A; Zoppoli P; Ceccarelli M; Botti G; Malanga D; Viglietto G
PLoS One; 2012; 7(2):e30427. PubMed ID: 22363436
[TBL] [Abstract][Full Text] [Related]
16. Characterization of germline mutations in familial lung cancer from the Chinese population.
Kanwal M; Ding XJ; Ma ZH; Li LW; Wang P; Chen Y; Huang YC; Cao Y
Gene; 2018 Jan; 641():94-104. PubMed ID: 29054765
[TBL] [Abstract][Full Text] [Related]
17. Genetic variations in the PI3K/AKT pathway predict platinum-based neoadjuvant chemotherapeutic sensitivity in squamous cervical cancer.
Guo L; Wu H; Zhu J; Zhang C; Ma J; Lan J; Xie X
Life Sci; 2015 Dec; 143():217-24. PubMed ID: 26585822
[TBL] [Abstract][Full Text] [Related]
18. Genetic variants in PI3K/AKT pathway are associated with severe radiation pneumonitis in lung cancer patients treated with radiation therapy.
Tang Y; Liu B; Li J; Wu H; Yang J; Zhou X; Yi M; Li Q; Yu S; Yuan X
Cancer Med; 2016 Jan; 5(1):24-32. PubMed ID: 26645682
[TBL] [Abstract][Full Text] [Related]
19. Associations between single-nucleotide polymorphisms in the PI3K-PTEN-AKT-mTOR pathway and increased risk of brain metastasis in patients with non-small cell lung cancer.
Li Q; Yang J; Yu Q; Wu H; Liu B; Xiong H; Hu G; Zhao J; Yuan X; Liao Z
Clin Cancer Res; 2013 Nov; 19(22):6252-60. PubMed ID: 24077347
[TBL] [Abstract][Full Text] [Related]
20. Germline mutations causing familial lung cancer.
Tomoshige K; Matsumoto K; Tsuchiya T; Oikawa M; Miyazaki T; Yamasaki N; Mishima H; Kinoshita A; Kubo T; Fukushima K; Yoshiura K; Nagayasu T
J Hum Genet; 2015 Oct; 60(10):597-603. PubMed ID: 26178433
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
